Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
07:06pm, Wednesday, 10'th Apr 2024
Vertex Pharmaceuticals (VRTX) reachead $397.58 at the closing of the latest trading day, reflecting a -1.71% change compared to its last close.
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion
05:15pm, Wednesday, 10'th Apr 2024
Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up.
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
04:45pm, Wednesday, 10'th Apr 2024
Vertex Pharmaceuticals will pay $4.9 billion to acquire Alpine Immune Sciences. Alpine stock rocketed.
Vertex Pharmaceuticals to buy Alpine Immune Sciences for $4.9 bln
04:20pm, Wednesday, 10'th Apr 2024
Vertex Pharmaceuticals will acquire therapy developer Alpine Immune Sciences for $65 per share, or about $4.9 billion in cash, the companies said on Wednesday.
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
09:27am, Wednesday, 10'th Apr 2024
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Vertex to Announce First Quarter 2024 Financial Results on May 6
04:05pm, Tuesday, 09'th Apr 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2024 financial results on Monday, May 6, 2024 after the financial markets close. The company w
This Growth Stock Is One Step Closer to Launching a New Blockbuster: Time to Buy?
10:07am, Tuesday, 09'th Apr 2024
Vertex Pharmaceuticals is starting a late-stage study for a promising candidate. In a best-case scenario, it could be as successful as the biotech's current top-seller.
Got $1,000? 2 Bulletproof Stocks to Buy in 2024 and Hold for the Long Haul
09:30am, Friday, 05'th Apr 2024
The healthcare industry is full of promising opportunities for every type of investor. UnitedHealth Group's established presence spans insurance to managed care services.
3 Underappreciated Healthcare Stocks to Buy Now: April 2024
08:02pm, Wednesday, 03'rd Apr 2024
The healthcare sector is a constant source of innovation and growth. Yet, even amidst the spotlight on industry giants, a realm of underappreciated gems still exists.
Biotech Sector Nears Breakout: Will it Outperform in Q2?
06:11am, Wednesday, 03'rd Apr 2024
The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.
Vertex (VRTX) Moves Kidney Disease Drug to Phase 3 Development
12:31pm, Tuesday, 02'nd Apr 2024
Vertex (VRTX) advances inaxaplin to late-stage development. It will evaluate the drug in lower age groups and will enroll patients aged 10 years and older with APOL1-mediated kidney disease.
Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to Know
06:56pm, Monday, 01'st Apr 2024
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $420.48, denoting a +0.59% change from the preceding trading day.
1 Top Growth Stock to Buy and Hold Forever
09:15am, Sunday, 31'st Mar 2024
Vertex Pharmaceuticals has an impeccable track record of innovation. The company recently reported important clinical progress.
Brokers Suggest Investing in Vertex (VRTX): Read This Before Placing a Bet
10:30am, Thursday, 28'th Mar 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Three top U.S. biotech stocks to buy in April
09:06am, Thursday, 28'th Mar 2024
“Biotech industry has found its footing again”, says Karen Andersen – a Morningstar strategist. Here are the top U.S. based stocks within this space that are particularly worth owning for 2024.
